GLP-1 retseptori agonistide kliiniline tõenduspõhisus ja kulutõhusus 2. tüüpi diabeedi ravis: tervisetehnoloogia hindamise raport TTH33
dc.contributor.author | Juus, Eva | |
dc.contributor.author | Volke, Vallo | |
dc.contributor.author | Roosimaa, Mart | |
dc.contributor.author | Lutsar, Katrin | |
dc.contributor.author | Lukka, Mari | |
dc.contributor.author | Kiivet, Raul-Allan | |
dc.contributor.other | Tartu ülikool. Peremeditsiini ja rahvatervishoiu instituut | |
dc.date.accessioned | 2018-03-21T14:19:15Z | |
dc.date.accessioned | 2022-09-21T08:46:22Z | |
dc.date.available | 2018-03-21T14:19:15Z | |
dc.date.available | 2022-09-21T08:46:22Z | |
dc.date.issued | 2017 | |
dc.description | Report in Estonian, summary in English | |
dc.identifier.uri | http://hdl.handle.net/10062/84152 | |
dc.publisher | Tartu | |
dc.subject | diabeet | |
dc.subject | ravimid | |
dc.subject | kulutõhusus | |
dc.subject | tervisetehnoloogiate hindamine | |
dc.subject | health technology assessment | |
dc.title | GLP-1 retseptori agonistide kliiniline tõenduspõhisus ja kulutõhusus 2. tüüpi diabeedi ravis: tervisetehnoloogia hindamise raport TTH33 | |
dc.title.alternative | The clinical effectiveness and cost-effectiveness of GLP-1 receptor agonists for the treatment of type 2 diabetes mellitus in Estonia: health technology assessment report HTA33 | |
dc.type | TTH_raport |
Files
License bundle
1 - 1 of 1